| Alexithymia and body image in adult outpatients with binge eating disorder A Carano, D De Berardis, F Gambi, C Di Paolo, D Campanella, L Pelusi, ... International Journal of Eating Disorders 39 (4), 332-340, 2006 | 181 | 2006 |
| Alexithymia and its relationships with dissociative experiences and Internet addiction in a nonclinical sample D De Berardis, A D'Albenzio, F Gambi, G Sepede, A Valchera, CM Conti, ... CyberPsychology & Behavior 12 (1), 67-69, 2009 | 156 | 2009 |
| Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study G Martinotti, G Sepede, F Gambi, G Di Iorio, D De Berardis, M Di Nicola, ... Journal of clinical psychopharmacology 32 (4), 487-491, 2012 | 141 | 2012 |
| Insight and alexithymia in adult outpatients with obsessive–compulsive disorder D De Berardis, D Campanella, F Gambi, G Sepede, G Salini, A Carano, ... European archives of psychiatry and clinical neuroscience 255 (5), 350-358, 2005 | 138 | 2005 |
| Affective and cognitive empathy in adolescents with autism spectrum disorder M Mazza, MC Pino, M Mariano, D Tempesta, M Ferrara, D De Berardis, ... Frontiers in human neuroscience 8, 791, 2014 | 121 | 2014 |
| Alexithymia and its relationships with body checking and body image in a non-clinical female sample D De Berardis, A Carano, F Gambi, D Campanella, P Giannetti, A Ceci, ... Eating behaviors 8 (3), 296-304, 2007 | 110 | 2007 |
| Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review G Martinotti, G Di Iorio, S Marini, V Ricci, D De Berardis, ... Journal of biological regulators and homeostatic agents 26 (3), 347, 2012 | 92 | 2012 |
| The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature D De Berardis, CMV Conti, N Serroni, FS Moschetta, L Olivieri, A Carano, ... International Journal of Immunopathology and Pharmacology 23 (2), 417-422, 2010 | 92 | 2010 |
| The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine D De Berardis, G Di Iorio, T Acciavatti, C Conti, N Serroni, L Olivieri, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2011 | 90 | 2011 |
| Role of melatonin in mood disorders and the antidepressant effects of agomelatine V Srinivasan, D De Berardis, SD Shillcutt, A Brzezinski Expert opinion on investigational drugs 21 (10), 1503-1522, 2012 | 89 | 2012 |
| An update of safety of clinically used atypical antipsychotics L Orsolini, C Tomasetti, A Valchera, R Vecchiotti, I Matarazzo, F Vellante, ... Expert opinion on drug safety 15 (10), 1329-1347, 2016 | 84 | 2016 |
| Major depressive disorder, anhedonia and agomelatine: an open-label study. M Di Giannantonio, G Di Iorio, R Guglielmo, D De Berardis, CM Conti, ... Journal of Biological Regulators and Homeostatic Agents 25 (1), 109-114, 2011 | 84 | 2011 |
| Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial G Sepede, D De Berardis, F Gambi, D Campanella, R La Rovere, ... Journal of Clinical Psychopharmacology 26 (1), 45-49, 2006 | 83 | 2006 |
| Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study F Gambi, D De Berardis, D Campanella, A Carano, G Sepede, G Salini, ... Journal of psychopharmacology 19 (5), 483-487, 2005 | 83 | 2005 |
| Alexithymia and suicide risk in psychiatric disorders: a mini-review D De Berardis, M Fornaro, L Orsolini, A Valchera, A Carano, F Vellante, ... Frontiers in psychiatry 8, 148, 2017 | 82 | 2017 |
| Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant … F Iasevoli, S Giordano, R Balletta, G Latte, MV Formato, E Prinzivalli, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, 34-48, 2016 | 81 | 2016 |
| Out of touch with reality? Social perception in first-episode schizophrenia SJH Ebisch, A Salone, F Ferri, D De Berardis, GL Romani, FM Ferro, ... Social cognitive and affective neuroscience 8 (4), 394-403, 2013 | 80 | 2013 |
| The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice D De Berardis, S Marini, M Fornaro, V Srinivasan, F Iasevoli, C Tomasetti, ... International journal of molecular sciences 14 (6), 12458-12483, 2013 | 78 | 2013 |
| Suicide during perinatal period: epidemiology, risk factors, and clinical correlates L Orsolini, A Valchera, R Vecchiotti, C Tomasetti, F Iasevoli, M Fornaro, ... Frontiers in psychiatry 7, 138, 2016 | 74 | 2016 |
| Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis S Galderisi, P Rucci, B Kirkpatrick, A Mucci, D Gibertoni, P Rocca, A Rossi, ... JAMA psychiatry 75 (4), 396-404, 2018 | 73 | 2018 |
